Artificial skin for closure and healing of wounds created by skin cancer excisions

Dermatologic Surgery

Volumn 27, Issue 7, 2001, Pages 648-655

  Prystowsky, Janet Hill ^a   Siegel, Daniel M ^b   Ascherman, Jeffrey A ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; DERMATOLOGICAL AGENT; GLYCOSAMINOGLYCAN; SILICONE;

ADULT; AGED; ARTICLE; ARTIFICIAL SKIN; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EPITHELIZATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SKIN CANCER; TISSUE REGENERATION; WOUND; WOUND CARE; WOUND CLOSURE; WOUND DRESSING; WOUND HEALING;

EID: 0034932363     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.2001.00340.x     Document Type: Article

References (8)

1. Artificial dermis for major burns: A multi-center randomized clinical trial
2. Artificial skin (Integra™ dermal regeneration template) for closure of lower extremity wounds
3. Histologic study of artificial skin used in treatment of full-thickness thermal injury
4. A composite skin substitute (graftskin) for surgical wounds: A clinical experience
5. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent
6. Cutaneous wound healing
7. Clinical safety of becaplermin (rhPDGF-BB) gel